Secondhand smoke, vascular disease, and dementia incidence: Findings from the cardiovascular health cognition study

American Journal of Epidemiology

Volumn 171, Issue 3, 2010, Pages 292-302

  Barnes, Deborah E ^a,b   Haight, Thaddeus J ^d   Mehta, Kala M ^b,c   Carlson, Michelle C ^e   Kuller, Lewis H ^f   Tager, Ira B ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aged; Dementia; Longitudinal studies; Models, statistical; Tobacco smoke pollution

Indexed keywords

AGE; CARDIOVASCULAR DISEASE; COGNITION; DISEASE INCIDENCE; HEALTH RISK; HEALTH SURVEY; MENTAL HEALTH; NUMERICAL MODEL; POLLUTION EXPOSURE; SMOKE; TOBACCO;

AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CIGARETTE SMOKING; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PASSIVE SMOKING; RISK FACTOR; SELF REPORT; VASCULAR DISEASE;

AGED; DEMENTIA; FEMALE; HUMANS; INCIDENCE; MALE; RISK FACTORS; TOBACCO SMOKE POLLUTION; VASCULAR DISEASES;

UNITED STATES;

NICOTIANA TABACUM;

EID: 75149188806     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp376     Document Type: Article

References (49)

1. California Environmental Protection Agency: Air Resources Board and Office of Environmental Health Hazard Assessment. Proposed identification of environmental tobacco smoke as a toxic air contaminant as approved by the Scientific Review Panel on June 24, 2005 (Appendix III). Sacramento, CA: California Environmental Protection Agency, June 24, 2005. (ftp://ftp.arb.ca. gov/carbis/regact/ets2006/app3exe.pdf). (Accessed October 7, 2009)
2. US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; June 27, 2006. http://www.surgeongeneral.gov/library/secondhandsmoke/)
3. Llewellyn DJ, Lang IA, Langa KM, et al. Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement [electronic article]. BMJ. 2009;338:b462.
4. Elrod K, Buccafusco JJ, Jackson WJ. Nicotine enhances delayed matching-to-sample performance by primates. Life Sci. 1988;43(3):277-287.
5. Salomon AR, Marcinowski KJ, Friedland RP, et al. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry. 1996;35(42):13568-13578.
6. Lee PN. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology. 1994;13(4): 131-144.
7. Van Duijn CM, Clayton DG, Chandra V, et al. Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. EURO-DEM Risk Factors Research Group. Genet Epidemiol. 1994; 11(6):539-551.
8. Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17(3):259-273.
9. Reitz C, Luchsinger J, Tang MX, et al. Effect of smoking and time on cognitive function in the elderly without dementia. Neurology. 2005;65(6):870-875. (Pubitemid 41362132)
10. Almeida OP, Hulse GK, Lawrence D, et al. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction. 2002;97(1):15-28.
11. Anstey KJ, von Sanden C, Salim A, et al. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166(4):367-378.
12. Hernán MA, Alonso A, Logroscino G. Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology. 2008;19(3):448-450.
13. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111(20): 2684-2698.
14. Zhang X, Shu XO, Yang G, et al. Association of passive smoking by husbands with prevalence of stroke among Chinese women nonsmokers. Am J Epidemiol. 2005;161(3): 213-218.
15. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277(10):813-817.
16. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215-1222.
17. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the Cardiovascular Health Cognition Study. Neuro-epidemiology. 2003;22(1):13-22.
18. Mathiesen EB, Waterloo K, Joakimsen O, et al. Reduced neuropsychological test performance in asymptomatic carotid stenosis: the Tromsø Study. Neurology. 2004;62(5):695-701.
19. Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009;40(4): 1229-1236.
20. Newman AB, Fitzpatrick AL, Lopez O, et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005;53(7):1101-1107.
21. Hanon O, Haulon S, Lenoir H, et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke. 2005;36(10):2193-2197.
22. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52(2):195-204.
23. Lopez OL, Kuller LH, Fitzpatrick A, et al. Evaluation of dementia in the Cardiovascular Health Cognition Study. Neuro-epidemiology. 2003;22(1):1-12. (Pubitemid 36131968)
24. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3): 263-276.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
26. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42(3 pt 1):473-480.
27. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
28. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43(2):250-260.
29. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5(4):278-285.
30. Psaty BM, Kuller LH, Bild D, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5(4):270-277.
31. Bryan RN, Manolio TA, Schertz LD, et al. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the Cardiovascular Health Study. AJNR Am J Neuro-radiol. 1994;15(9):1625-1633.
32. Manolio TA, Kronmal RA, Burke GL, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke. 1994;25(2): 318-327.
33. O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke. 1992;23(12):1752-1760.
34. Radloff LS. A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1: 385-401.
35. Eisner MD, Wang Y, Haight TJ, et al. Secondhand smoke exposure, pulmonary function, and cardiovascular mortality. Ann Epidemiol. 2007;17(5):364-373.
36. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11(5): 561-570.
37. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560.
38. Tager IB, Haight T, Sternfeld B, et al. Effects of physical activity and body composition on functional limitation in the elderly: application of the marginal structural model. Epidemiology. 2004;15(4):479-493.
39. Petersen ML, Sinisi SE, van der Laan MJ. Estimation of direct causal effects. Epidemiology. 2006;17(3):276-284.
40. Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 1992;3(2): 143-155.
41. Weinberg CR. Toward a clearer definition of confounding. Am J Epidemiol. 1993;137(1):1-8.
42. Rush D, Callahan KR. Exposure to passive cigarette smoking and child development. A critical review. Ann N Y Acad Sci. 1989;562:74-100.
43. Yolton K, Dietrich K, Auinger P, et al. Exposure to environmental tobacco smoke and cognitive abilities among U.S. children and adolescents. Environ Health Perspect. 2005; 113(1):98-103.
44. Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005;28(4):202-208.
45. Pollard KS, van der Laan MJ. Choice of a null distribution in resampling-based multiple testing. J Stat Plan Inference. 2004; 125:85-100.
46. van der Laan MJ, Robins J. Unified Methods for Censored Longitudinal Data and Causality. New York, NY: Springer-Verlag; 2002.
47. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46.
48. Robins JM. Association, causation, and marginal structural models. Synthese. 1999;121:151-179.
49. Greenland S, Robins J, Pearl J. Confounding and collapsibility in causal inference. Stat Sci. 1999;14:29-46.